MedPath

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

Not Applicable
Completed
Conditions
Pituitary Adenoma
Registration Number
NCT04074642
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • pituitary compressive adenoma (for experimental group)
  • pituitary non compressive adenoma
Exclusion Criteria
  • retinian disease
  • amblyopia
  • parkinson disease
  • pregnant woman

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
change of middle deviationbefore surgery (= inclusion), 4 months after surgery and 10 months after surgery

visual field evolution assessed by Middle deviation

Change of visual function indexbefore surgery (= inclusion), 4 months after surgery and 10 months after surgery

visual field evolution assessed by visual function index

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

CHU de NICE

🇫🇷

Nice, France

Hôpital Pasteur 2 - Service d'Ophtalmologie

🇫🇷

Nice, France

CHU de NICE
🇫🇷Nice, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.